Global Active Pharmaceutical Ingredients (API) Market Insights and Forecast to 2028

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market
Due to the COVID-19 pandemic, the global Active Pharmaceutical Ingredients (API) market size is estimated to be worth US$ 77250 million in 2022 and is forecast to a readjusted size of US$ 113360 million by 2028 with a CAGR of 6.6% during the review period. Fully considering the economic change by this health crisis, Synthetic APIs accounting for % of the Active Pharmaceutical Ingredients (API) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While CNS segment is altered to an % CAGR throughout this forecast period.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
In terms of production side, this report researches the Active Pharmaceutical Ingredients (API) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Active Pharmaceutical Ingredients (API) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Active Pharmaceutical Ingredients (API) Scope and Segment
Active Pharmaceutical Ingredients (API) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions